LMRI.US Lumexa Imaging Holdings, Inc. Common Stock
- Market cap
- USD 1.42B
- P/E
- -
- P/B
- 2.25x
- ROE
- 2.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is LMRI.US undervalued?
Graham numberThe Graham number of Lumexa Imaging Holdings, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Lumexa Imaging Holdings, Inc. Common Stock fundamental analysis
No fundamental analysis for Lumexa Imaging Holdings, Inc. Common Stock yet.
Lumexa Imaging Holdings, Inc. Common Stock stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Full company profileLumexa Imaging Holdings, Inc. Common Stock financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Lumexa Imaging Holdings, Inc. Common Stock annual financial statements
| Item | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 936M | 949M | 1.02B | 1.05B |
| Gross Profit | 99.0M | 96.3M | 117M | 133M |
| Operating Income | 22.4M | 55.2M | 26.7M | 18.9M |
| EBITDA | 94.6M | 114M | 142M | 119M |
| Net Income | -122M | -94.1M | -47.1M | 15.5M |
| EPS | -1.29 | -1.00 | -0.66 | 0.16 |
| Balance Sheet | ||||
| Total Assets | 1.67B | 1.67B | 1.76B | 1.83B |
| Total Liabilities | 1.47B | 1.51B | 1.18B | 1.20B |
| Shareholders' Equity | 198M | 162M | 586M | 634M |
| Cash & Short-term Investments | 20.2M | 26.1M | 58.8M | 90.0M |
| Total Debt | 1.30B | 1.31B | 963M | 975M |
| Cash Flow | ||||
| Operating Cash Flow | 37.5M | 40.7M | 17.1M | 94.1M |
| Capital Expenditure | 24.0M | 27.8M | 23.5M | 38.9M |
| Free Cash Flow | 13.5M | 13.0M | -6.40M | 55.1M |
| Ratios | ||||
| ROE | -61.6% | -58.2% | -8.0% | 2.4% |
| ROA | -7.3% | -5.6% | -2.7% | 0.8% |
| Net Profit Margin | -13.1% | -9.9% | -4.6% | 1.5% |
| Debt to Equity | 6.58x | 8.10x | 1.64x | 1.54x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Lumexa Imaging Holdings, Inc. Common Stock dividends
Lumexa Imaging Holdings, Inc. Common Stock has not paid dividends in the last 3 fiscal years.
Who owns Lumexa Imaging Holdings, Inc. Common Stock
- Insiders 80.76%
- Institutions 19.24%
- Public & others 0.00%
- Shares outstanding 96.1M
- Free float 22.1M
Top funds holding LMRI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Brown Advisory Small-Cap Fdmtl Val Inv | 2.20M | 2.29% | -1.26% | Sep 2026 |
| MFS New Discovery Value I | 1.50M | 1.56% | -4.64% | Sep 2026 |
| Bridge Builder Small Cap Fund | 827K | 0.86% | -1.07% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 761K | 0.79% | 0.00% | Sep 2026 |
| Janus Henderson Triton D | 611K | 0.64% | -40.45% | Sep 2026 |
| Royce Small-Cap Opportunity Invmt | 506K | 0.53% | +36.27% | Sep 2026 |
| iShares Russell 2000 ETF | 477K | 0.50% | 0.00% | Oct 2026 |
| FTGF RY US SmCp Opp A USD Dis(A) | 468K | 0.49% | +3.14% | Oct 2026 |
| MFS Core Equity A | 449K | 0.47% | -0.88% | Sep 2026 |
| First Eagle Small Cap Opportunity I | 391K | 0.41% | +71.65% | Sep 2026 |
| Brown Advisory Small-Cap Growth Inv | 367K | 0.38% | 0.00% | Sep 2026 |
| Janus Henderson Venture D | 366K | 0.38% | -40.45% | Sep 2026 |
| Principal SmallCap Growth I Instl | 333K | 0.35% | 0.00% | Sep 2026 |
| Brown Advisory US SmlrComs Dollar B Acc | 330K | 0.34% | 0.00% | Sep 2026 |
| Virtus KAR Health Sciences A | 293K | 0.30% | -4.14% | Jun 2026 |
| Putnam Small Cap Value A | 262K | 0.27% | -4.37% | Sep 2026 |
| Fidelity Small Cap Index | 208K | 0.22% | 0.00% | Aug 2026 |
| iShares Russell 2000 Value ETF | 181K | 0.19% | 0.00% | Oct 2026 |
| Omnis US Smaller Companies A Inc | 175K | 0.18% | -8.39% | Jul 2026 |
| Fidelity Select Health Care Svcs Port | 151K | 0.16% | 0.00% | Sep 2026 |
Top institutions holding LMRI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Brown Advisory Holdings Inc | 5.78M | 6.01% | +238.85% | Jun 2026 |
| Massachusetts Financial Services Company | 3.45M | 3.60% | +47.94% | Jun 2026 |
| Think Investments LP | 2.56M | 2.66% | 0.00% | Jun 2026 |
| Jupiter Topco LLC | 2.15M | 2.24% | 0.00% | Jun 2026 |
| BlackRock Inc | 1.40M | 1.46% | -8.36% | Jun 2026 |
| JPMorgan Chase & Co | 1.15M | 1.20% | +4.52% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.07M | 1.11% | +1.12% | Jun 2026 |
| The Goldman Sachs Group Inc | 807K | 0.84% | +5.48% | Jun 2026 |
| Royce & Associates, LP | 789K | 0.82% | +139.10% | Jun 2026 |
| Schonfeld Strategic Advisors LLC | 769K | 0.80% | +283.10% | Jun 2026 |
| Brigade Capital Management LP | 666K | 0.69% | 0.00% | Jun 2026 |
| RTW INVESTMENTS, LLC | 650K | 0.68% | 0.00% | Jun 2026 |
| Millennium Management LLC | 628K | 0.65% | -12.13% | Jun 2026 |
| Geode Capital Management, LLC | 626K | 0.65% | -7.09% | Jun 2026 |
| Adage Capital Partners Gp LLC | 625K | 0.65% | +49.40% | Jun 2026 |
| ArrowMark Colorado Holdings, LLC (ArrowMark Partners) | 602K | 0.63% | -63.58% | Jun 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 600K | 0.62% | -53.85% | Jun 2026 |
| Longaeva Partners L.P. | 529K | 0.55% | -5.13% | Jun 2026 |
| Silvercrest Asset Management Group LLC | 467K | 0.49% | 0.00% | Jun 2026 |
| State Street Corp | 459K | 0.48% | +21.85% | Jun 2026 |
Lumexa Imaging Holdings, Inc. Common Stock company profile
- Company name
- Lumexa Imaging Holdings, Inc. Common Stock
- Ticker
- LMRI.US
- Exchange
- USA Stocks
- Listed since
- Dec 11, 2025
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 5,000
- Fiscal year end
- December
- Address
- 4200 Six Forks Road, Raleigh, NC, United States, 27609
- Phone
- 919 763 1100
- Website
- lumexaimaging.com
About Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Lumexa Imaging Holdings, Inc. Common Stock management
10- Mr. Henry Lee CooperExecutive Chairman · born 1963
- Ms. Caitlin ZullaCEO & Director · born 1979
- Mr. J. Anthony MartinChief Financial Officer · born 1972
- James E. Walker Jr.Chief Accounting Officer
- Mr. Lachlan TidmarshChief Information Officer
- Mr. Paul GilbertChief Legal Officer & Corporate Secretary
- Ms. Jill LewandowskiChief People Officer
- Dr. Russell Stewart M.B.A., M.D., M.S.Chief Medical Officer · born 1978
- Mr. Rick GrodinDivision President
- Mr. Chris RobertsonChief Revenue Officer